Anish John

2023

In 2023, Anish John earned a total compensation of $449.2K as Former Chief Financial Officer at Oncocyte Corp, a 39% decrease compared to previous year.

Compensation breakdown

Option Awards$97,198
Salary$147,138
Other$204,826
Total$449,161

John received $204.8K in other compensation, accounting for 46% of the total pay in 2023.

John also received $97.2K in option awards and $147.1K in salary.

Rankings

In 2023, Anish John's compensation ranked 2,067th out of 2,790 executives tracked by ExecPay. In other words, John earned more than 25.9% of executives.

ClassificationRankingPercentile
All
2,067
out of 2,790
26th
Division
Manufacturing
1,168
out of 1,530
24th
Major group
Chemicals And Allied Products
713
out of 869
18th
Industry group
Drugs
695
out of 832
17th
Industry
In Vitro and In Vivo Diagnostic Substances
8
out of 14
43rd
Source: SEC filing on April 29, 2024.

John's colleagues

We found three more compensation records of executives who worked with Anish John at Oncocyte Corp in 2023.

2023

Joshua Riggs

Oncocyte Corp

Chief Executive Officer

2023

Ekkehard Schütz

Oncocyte Corp

Chief Scientific Officer

2023

James Liu

Oncocyte Corp

Controller and Principal Accounting Officer

News

You may also like